Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam and SBI for Chemotherapy-Induced Diarrhea in Multiple Myeloma
NCT02619812Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Apr 2016
- Primary completion
- Dec 2016
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of colesevelam, serum-derived bovine immunoglobulin/protein isolate in diarrhea, sponsored by Mayo Clinic. Started Apr 2016; status: terminated.
02
Drugs
colesevelamserum-derived bovine immunoglobulin/protein isolate
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02619812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619812.